Back

Health and economic impact of geographically prioritized long-acting PrEP delivery in southern and eastern Africa

2026-02-26 hiv aids Title + abstract only
View on medRxiv
Show abstract

BackgroundLong-acting injectable HIV pre-exposure prophylaxis (PrEP), including Lenacapavir, has the potential to accelerate HIV incidence declines in eastern and southern Africa (ESA). However, high product and delivery costs and constrained budgets necessitate efficient prioritization strategies to maximize impact and achieve cost-effectiveness. MethodsWe used district-level HIV incidence estimates published by UNAIDS to estimate the direct health and economic impact of prioritizing Lenacapav...

Predicted journal destinations